George Heinrich, chief executive of Foundation Venture Capital Group, said: "The link between gum disease and cardiovascular disease is strong enough for us to consider that Dr Fine's [Affineti founder Daniel Fine who is also a professor and chair at Department of Oral Biology at University of Medicine and Dentistry of New Jersey-New Jersey Dental School] research will impact health on many levels."
Foundation Venture Capital Group, an affiliate of New Jersey Health Foundation that backs start-up companies developing technology by faculty at the University of Medicine and Dentistry of New Jersey, has invested $500,000 in US-based dental hygiene company Affineti Biologics.
George Heinrich, chief executive of Foundation Venture Capital Group, said: "The link between gum disease and cardiovascular disease is strong enough for us to consider that Dr Fine’s [Affineti founder Daniel Fine who is also a professor and chair at Department…
